Department of Radiology, Scott & White Clinic and Hospital, Texas A&M University Health Science Center, Temple, TX, USA.
Invest Radiol. 2011 Mar;46(3):169-77. doi: 10.1097/RLI.0b013e3181f7a0b0.
To compare a fibrin-targeted, high relaxivity gadolinium tetramer, EP-2104R, in terms of magnitude of contrast enhancement (CE) and temporal time course, to a conventional extracellular gadolinium chelate, in a brain glioma model at 1.5-T magnetic resonance imaging.
Six rats were evaluated, with each animal receiving (for separate studies) 0.05 mmol/kg gadopentetate dimeglumine (Gd DTPA or Magnevist) and 0.0125 mmol/kg of EP-2104R, with the 2 magnetic resonance examinations separated in each animal by 24 hours. The compound (EP-2104R) was synthesized using published methodology, being comprised of an 11 amino acid peptide derivatized at both the C- and N-termini with Gd-DOTA-like (Dotarem-like) moieties. T1-weighted scans were acquired precontrast and for 5 consecutive 2-minute intervals postcontrast, and subsequently at 15 and 20 minutes postcontrast.
Maximum tumor contrast-to-noise and CE both occurred at 1 minute versus at 5 minutes following administration of Gd DTPA versus EP-2104R, respectively. Utilizing an equivalent dose on a Gd ion per body weight basis, signal-to-noise, contrast-to-noise, and CE were greater for EP-2104R at all time points postcontrast, yielding overall statistically significantly greater levels of all 3 parameters with the latter. With EP-2104R, improvements in CE ranged between 87% and 391%, increasing at each measured time postcontrast with the exception of a slight decrease from 15 to 20 minutes postadministration. Histopathology confirmed, using immunofluorescence technique, abnormally increased fibrin within the tumor.
Statistically significantly greater brain tumor enhancement was noted with greater lesion enhancement at all observed time points postcontrast for EP-2104R utilizing an equivalent concentration to Gd DTPA on a per gadolinium ion basis. These findings together with the prolonged time course of enhancement suggest possible fibrin-binding and altered distribution kinetics.
在 1.5T 磁共振成像中,比较一种纤维蛋白靶向、高弛豫率的钆四聚体 EP-2104R 与常规细胞外钆螯合物在脑胶质瘤模型中的对比增强(CE)幅度和时间过程。
对 6 只大鼠进行评估,每只动物分别接受(分别进行研究)0.05mmol/kg 钆喷替酸二甲葡胺(Gd DTPA 或马根维显)和 0.0125mmol/kg 的 EP-2104R,两次磁共振检查在每只动物中相隔 24 小时。该化合物(EP-2104R)是使用已发表的方法合成的,由在 C-和 N-末端均衍生有 Gd-DOTA 样(Dotarem 样)部分的 11 个氨基酸肽组成。在注射前和注射后连续 5 分钟采集 T1 加权扫描,并在注射后 15 分钟和 20 分钟进行采集。
与 Gd DTPA 相比,EP-2104R 在注射后 1 分钟和 5 分钟时肿瘤的最大对比噪声比(CNR)和 CE 均最高。利用基于体重的每个 Gd 离子的等效剂量,在所有时间点的 EP-2104R 的信号噪声比、CNR 和 CE 均更高,后者的所有 3 个参数的水平总体上均具有统计学意义的显著提高。EP-2104R 的 CE 改善范围在 87%至 391%之间,在每个测量的注射后时间点增加,除了在注射后 15 分钟至 20 分钟之间略有下降。使用免疫荧光技术的组织病理学证实肿瘤内异常增加的纤维蛋白。
与 Gd DTPA 相比,EP-2104R 在基于每个 Gd 离子的等效浓度下,在所有观察到的注射后时间点的脑肿瘤增强均具有统计学意义的显著提高,并且在所有观察到的注射后时间点的肿瘤增强均更高。这些发现以及增强的延长时间过程提示可能与纤维蛋白结合和分布动力学改变有关。